STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2017

Stockholders' Equity Note [Abstract]

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

These fair values were derived using the BSM with the following weighted-average assumptions:

	For the Years Ended December 31,
	2017			2016
Average risk-free interest rate		1.81	%		—
Expected dividend yield		0.00	%		—
Expected lives		6.00 years			—
Expected volatility		65.8	%		—

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

Transactions and other information relating to stock options for the years December 31, 2017 and 2016 are summarized below:

	Number of Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Term (In Years)		Aggregate Intrinsic Value
Outstanding at December 31, 2015		3,712,000	$	2.06		5.20	$	733,000
Grants		—	$	—
Exercised		—	$	—
Forfeited/cancelled/expired		(12,000)	$	10.66
Outstanding at December 31, 2016		3,700,000	$	2.03		4.21	$	3,675,000
Grants		1,204,000	$	1.90
Exercised		—	$	—
Forfeited/cancelled/expired		(100,000)	$	7.50
Outstanding at December 31, 2017		4,804,000	$	1.89		4.90	$	795,000
Vested and expected to vest at December 31, 2017		4,707,000	$	1.88		4.81	$	795,000
Unvested at December 31, 2017		1,304,000	$	1.91		9.47	$	—
Exercisable at December 31, 2017		3,500,000	$	1.88		3.20	$	795,000

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]

Transactions and other information relating to restricted stock grants for the years ended December 31, 2017 and 2016 are summarized below: 

	Shares		Average Fair Value at Grant Date
Unvested at December 31, 2015		953,000	$	2.76
Grants		238,000	$	2.22
Vested		(788,000)	$	2.80
Forfeited/cancelled/expired		(45,000)	$	2.75
Unvested at December 31, 2016		358,000	$	2.31
Grants		2,210,000	$	1.91
Vested		(265,000)	$	2.22
Forfeited/cancelled/expired		—	$	—
Unvested at December 31, 2017		2,303,000	$	1.94